drugset / Trial / NCT02432339

Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

NCT02432339

Phase 1/2 Unknown 50 enrolled Augusta University
RandomizedCrossoverTriple-blindPrevention

Summary

The purpose of this study is to determine if stopping the stress induced increase in inflammation will prevent sodium retention which in turn increases blood pressure. Each subject will test two separate times. One week, they will be taking a daily dose of mycophenolate mofetil (MMF), the other week they will be taking a placebo.

Timeline

Start
2014-04-22
Primary completion
2019-11
Completion
2019-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Mofetil Small molecule 500 mg

Indications